Binding of PLCdelta1PH-GFP to PtdIns(4,5)P2 prevents inhibition of phospholipase C-mediated hydrolysis of PtdIns(4,5)P2 by neomycin

Acta Pharmacol Sin. 2005 Dec;26(12):1485-91. doi: 10.1111/j.1745-7254.2005.00223.x.

Abstract

Aim: To investigate the effects of the pleckstrin homology (PH) domain of phospholipase C(delta1) (PLC(delta1)PH) on inhibition of phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] by neomycin.

Methods: A fusion construct of green fluorescent protein (GFP) and PLC (delta1)PH (PLC(delta1)PH-GFP), which is known to bind PtdIns(4,5)P2 specifically, together with laser-scanning confocal microscopy, was used to trace PtdIns(4,5)P2 translocation.

Results: Stimulation of the type 1 muscarinic receptor and the bradykinin 2 receptor induced a reversible PLC(delta1)PH-GFP translocation from the membrane to the cytosol in COS-7 cells. PLC inhibitor U73122 blocked the translocation. Wortmannin, a known PtdIns kinase inhibitor, did not affect the translocation induced by ACh, but blocked recovery after translocation, indicating that PtdIns(4,5)P2 hydrolysis occurs through receptor-mediated PLC activation. Neomycin, a commonly used phospholipase C blocker, failed to block the receptor-induced PLCd1PH-GFP translocation, indicating that neomycin is unable to block PLC-mediated PtdIns(4,5)P2 hydrolysis. However, in the absence of PLCd1PH-GFP expression, neomycin abolished the receptor-induced hydrolysis of PtdIns(4,5)P2 by PLC.

Conclusion: Although PLCd1PH and neomycin bind to PtdIns(4,5)P2 in a similar way, they have distinct effects on receptor-mediated activation of PLC and PtdIns(4,5)P2 hydrolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Androstadienes / pharmacology
  • Animals
  • Bradykinin / pharmacology
  • COS Cells / cytology
  • Cell Membrane / metabolism
  • Chlorocebus aethiops
  • Cytosol / metabolism
  • Estrenes / pharmacology
  • Green Fluorescent Proteins / metabolism
  • Hydrolysis
  • Isoenzymes / metabolism*
  • Neomycin / pharmacology*
  • Phosphatidylinositol 4,5-Diphosphate
  • Phosphatidylinositol Phosphates / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Phospholipase C delta
  • Protein Binding
  • Protein Transport / drug effects
  • Pyrrolidinones / pharmacology
  • Receptor, Bradykinin B2 / metabolism
  • Receptors, Muscarinic / metabolism
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism*
  • Wortmannin

Substances

  • Androstadienes
  • Estrenes
  • Isoenzymes
  • Phosphatidylinositol 4,5-Diphosphate
  • Phosphatidylinositol Phosphates
  • Phosphoinositide-3 Kinase Inhibitors
  • Pyrrolidinones
  • Receptor, Bradykinin B2
  • Receptors, Muscarinic
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Green Fluorescent Proteins
  • Type C Phospholipases
  • Phospholipase C delta
  • Neomycin
  • Acetylcholine
  • Bradykinin
  • Wortmannin